nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—PHKG2—thyroid gland—bipolar disorder	0.0124	0.0452	CbGeAlD
Afatinib—ERBB4—thyroid gland—bipolar disorder	0.0111	0.0407	CbGeAlD
Afatinib—ERBB2—thyroid gland—bipolar disorder	0.0111	0.0407	CbGeAlD
Afatinib—EPHA6—nervous system—bipolar disorder	0.0108	0.0394	CbGeAlD
Afatinib—DYRK1A—thyroid gland—bipolar disorder	0.0107	0.0391	CbGeAlD
Afatinib—HIPK4—brain—bipolar disorder	0.0104	0.0381	CbGeAlD
Afatinib—PHKG2—nervous system—bipolar disorder	0.0104	0.038	CbGeAlD
Afatinib—PHKG2—cerebellum—bipolar disorder	0.00979	0.0358	CbGeAlD
Afatinib—EGFR—thyroid gland—bipolar disorder	0.00943	0.0345	CbGeAlD
Afatinib—ERBB2—nervous system—bipolar disorder	0.00935	0.0342	CbGeAlD
Afatinib—ERBB4—nervous system—bipolar disorder	0.00935	0.0342	CbGeAlD
Afatinib—DYRK1A—nervous system—bipolar disorder	0.009	0.0329	CbGeAlD
Afatinib—ERBB2—cerebellum—bipolar disorder	0.0088	0.0322	CbGeAlD
Afatinib—ERBB4—cerebellum—bipolar disorder	0.0088	0.0322	CbGeAlD
Afatinib—DYRK1A—cerebellum—bipolar disorder	0.00847	0.031	CbGeAlD
Afatinib—IRAK1—thyroid gland—bipolar disorder	0.00832	0.0304	CbGeAlD
Afatinib—EPHA6—brain—bipolar disorder	0.00824	0.0302	CbGeAlD
Afatinib—LCK—thyroid gland—bipolar disorder	0.00811	0.0297	CbGeAlD
Afatinib—PHKG2—brain—bipolar disorder	0.00795	0.0291	CbGeAlD
Afatinib—EGFR—cerebellum—bipolar disorder	0.00746	0.0273	CbGeAlD
Afatinib—ERBB4—brain—bipolar disorder	0.00715	0.0261	CbGeAlD
Afatinib—ERBB2—brain—bipolar disorder	0.00715	0.0261	CbGeAlD
Afatinib—DYRK1A—brain—bipolar disorder	0.00688	0.0252	CbGeAlD
Afatinib—ABL1—adrenal cortex—bipolar disorder	0.00669	0.0245	CbGeAlD
Afatinib—IRAK1—cerebellum—bipolar disorder	0.00658	0.0241	CbGeAlD
Afatinib—EGFR—brain—bipolar disorder	0.00606	0.0222	CbGeAlD
Afatinib—IRAK1—brain—bipolar disorder	0.00535	0.0196	CbGeAlD
Afatinib—ABL1—thyroid gland—bipolar disorder	0.00466	0.017	CbGeAlD
Afatinib—ABCG2—adrenal cortex—bipolar disorder	0.00422	0.0154	CbGeAlD
Afatinib—ABCB1—blood plasma—bipolar disorder	0.0041	0.015	CbGeAlD
Afatinib—ABL1—nervous system—bipolar disorder	0.00392	0.0143	CbGeAlD
Afatinib—ABL1—cerebellum—bipolar disorder	0.00369	0.0135	CbGeAlD
Afatinib—ABL1—brain—bipolar disorder	0.003	0.011	CbGeAlD
Afatinib—ABCG2—thyroid gland—bipolar disorder	0.00294	0.0107	CbGeAlD
Afatinib—ABCG2—cerebellum—bipolar disorder	0.00233	0.0085	CbGeAlD
Afatinib—ABCB1—adrenal cortex—bipolar disorder	0.00208	0.00761	CbGeAlD
Afatinib—ABCG2—brain—bipolar disorder	0.00189	0.00691	CbGeAlD
Afatinib—ABCB1—thyroid gland—bipolar disorder	0.00145	0.0053	CbGeAlD
Afatinib—ABCB1—nervous system—bipolar disorder	0.00122	0.00446	CbGeAlD
Afatinib—ABCB1—cerebellum—bipolar disorder	0.00115	0.00419	CbGeAlD
Afatinib—ABCB1—brain—bipolar disorder	0.000931	0.00341	CbGeAlD
Afatinib—IRAK1—Immune System—GSK3A—bipolar disorder	0.000191	0.000263	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—GSK3B—bipolar disorder	0.00019	0.000262	CbGpPWpGaD
Afatinib—ERBB2—Immune System—NRG1—bipolar disorder	0.000187	0.000257	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—ADM—bipolar disorder	0.000186	0.000257	CbGpPWpGaD
Afatinib—ERBB4—Immune System—NRG1—bipolar disorder	0.000184	0.000253	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HTR1A—bipolar disorder	0.000184	0.000253	CbGpPWpGaD
Afatinib—IRAK1—Immune System—HLA-E—bipolar disorder	0.000184	0.000253	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000182	0.000251	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—PDE4B—bipolar disorder	0.000182	0.00025	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—TSHB—bipolar disorder	0.000182	0.00025	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—TACR1—bipolar disorder	0.000182	0.00025	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—NR1D1—bipolar disorder	0.000182	0.00025	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—NRG1—bipolar disorder	0.000181	0.00025	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HTR1A—bipolar disorder	0.000181	0.000249	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000181	0.000249	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TAC1—bipolar disorder	0.000181	0.000249	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—AKR1C4—bipolar disorder	0.000181	0.000249	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—GSK3B—bipolar disorder	0.000179	0.000246	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TAC1—bipolar disorder	0.000178	0.000245	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HTR2C—bipolar disorder	0.000178	0.000244	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—DRD1—bipolar disorder	0.000178	0.000244	CbGpPWpGaD
Afatinib—BLK—Immune System—NRG1—bipolar disorder	0.000177	0.000244	CbGpPWpGaD
Afatinib—IRAK1—Immune System—ADCY2—bipolar disorder	0.000176	0.000242	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—S100B—bipolar disorder	0.000176	0.000242	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—DRD1—bipolar disorder	0.000175	0.000241	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HTR2C—bipolar disorder	0.000175	0.000241	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—AKR1C4—bipolar disorder	0.000174	0.00024	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—NCAN—bipolar disorder	0.000174	0.000239	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TRPC3—bipolar disorder	0.000173	0.000238	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—NTRK2—bipolar disorder	0.000173	0.000238	CbGpPWpGaD
Afatinib—ERBB2—Disease—NRG1—bipolar disorder	0.000172	0.000237	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—DRD3—bipolar disorder	0.000172	0.000237	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—GSK3A—bipolar disorder	0.000171	0.000236	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—SLC5A3—bipolar disorder	0.00017	0.000234	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—NTRK2—bipolar disorder	0.00017	0.000234	CbGpPWpGaD
Afatinib—ERBB4—Disease—NRG1—bipolar disorder	0.00017	0.000234	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—DRD3—bipolar disorder	0.000169	0.000233	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—S100B—bipolar disorder	0.000169	0.000233	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—GSK3A—bipolar disorder	0.000169	0.000232	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—GSK3B—bipolar disorder	0.000168	0.000232	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—DRD4—bipolar disorder	0.000167	0.00023	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—DGKH—bipolar disorder	0.000167	0.000229	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—ADM—bipolar disorder	0.000165	0.000227	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—DRD4—bipolar disorder	0.000164	0.000226	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—PDE4B—bipolar disorder	0.000161	0.000221	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TSHB—bipolar disorder	0.000161	0.000221	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TACR1—bipolar disorder	0.000161	0.000221	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—DGKH—bipolar disorder	0.000161	0.000221	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—ADCY2—bipolar disorder	0.000157	0.000216	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TCF7L2—bipolar disorder	0.000157	0.000216	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—DRD2—bipolar disorder	0.000156	0.000214	CbGpPWpGaD
Afatinib—ERBB2—Disease—MTHFR—bipolar disorder	0.000155	0.000214	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—NRG1—bipolar disorder	0.000155	0.000213	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—ADCY2—bipolar disorder	0.000155	0.000213	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TCF7L2—bipolar disorder	0.000154	0.000212	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—DRD2—bipolar disorder	0.000153	0.000211	CbGpPWpGaD
Afatinib—IRAK1—Immune System—S100B—bipolar disorder	0.000153	0.000211	CbGpPWpGaD
Afatinib—ERBB4—Disease—MTHFR—bipolar disorder	0.000153	0.000211	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—DRD5—bipolar disorder	0.000152	0.00021	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HTR1A—bipolar disorder	0.00015	0.000207	CbGpPWpGaD
Afatinib—ABL1—Immune System—GSK3A—bipolar disorder	0.00015	0.000206	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—NRG1—bipolar disorder	0.000149	0.000206	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—RGS4—bipolar disorder	0.000149	0.000206	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—GSK3B—bipolar disorder	0.000149	0.000205	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—NRG1—bipolar disorder	0.000149	0.000205	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000149	0.000205	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—TAC1—bipolar disorder	0.000148	0.000204	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—INS—bipolar disorder	0.000147	0.000203	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—DRD5—bipolar disorder	0.000147	0.000202	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HTR2C—bipolar disorder	0.000145	0.0002	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—DRD1—bipolar disorder	0.000145	0.0002	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—RGS4—bipolar disorder	0.000144	0.000198	CbGpPWpGaD
Afatinib—ABL1—Immune System—HLA-E—bipolar disorder	0.000144	0.000198	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—NRG1—bipolar disorder	0.000144	0.000198	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—IL1B—bipolar disorder	0.000142	0.000196	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—NTRK1—bipolar disorder	0.000141	0.000194	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—DRD3—bipolar disorder	0.000141	0.000194	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—NTRK1—bipolar disorder	0.000139	0.000191	CbGpPWpGaD
Afatinib—ABL1—Immune System—ADCY2—bipolar disorder	0.000137	0.000189	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—S100B—bipolar disorder	0.000137	0.000188	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—DRD4—bipolar disorder	0.000137	0.000188	CbGpPWpGaD
Afatinib—ERBB2—Immune System—GSK3B—bipolar disorder	0.000136	0.000187	CbGpPWpGaD
Afatinib—IRAK1—Immune System—NRG1—bipolar disorder	0.000135	0.000186	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—S100B—bipolar disorder	0.000135	0.000186	CbGpPWpGaD
Afatinib—ERBB4—Immune System—GSK3B—bipolar disorder	0.000134	0.000184	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HTR1A—bipolar disorder	0.000133	0.000183	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—IMPA1—bipolar disorder	0.000133	0.000183	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—GSK3B—bipolar disorder	0.000132	0.000181	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TAC1—bipolar disorder	0.000131	0.00018	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—ADCY2—bipolar disorder	0.000129	0.000177	CbGpPWpGaD
Afatinib—BLK—Immune System—GSK3B—bipolar disorder	0.000129	0.000177	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HTR2C—bipolar disorder	0.000128	0.000177	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—DRD1—bipolar disorder	0.000128	0.000177	CbGpPWpGaD
Afatinib—EGFR—Immune System—GSK3A—bipolar disorder	0.000128	0.000176	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—GSK3B—bipolar disorder	0.000127	0.000175	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—DRD2—bipolar disorder	0.000127	0.000175	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—INS—bipolar disorder	0.000126	0.000173	CbGpPWpGaD
Afatinib—ERBB2—Disease—GSK3B—bipolar disorder	0.000125	0.000172	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NTRK2—bipolar disorder	0.000125	0.000172	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—DRD3—bipolar disorder	0.000124	0.000171	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—GSK3A—bipolar disorder	0.000124	0.00017	CbGpPWpGaD
Afatinib—ERBB2—Disease—INS—bipolar disorder	0.000124	0.00017	CbGpPWpGaD
Afatinib—LCK—Immune System—GSK3A—bipolar disorder	0.000123	0.00017	CbGpPWpGaD
Afatinib—ERBB4—Disease—GSK3B—bipolar disorder	0.000123	0.00017	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CLOCK—bipolar disorder	0.000123	0.000169	CbGpPWpGaD
Afatinib—EGFR—Immune System—HLA-E—bipolar disorder	0.000123	0.000169	CbGpPWpGaD
Afatinib—EGFR—Disease—SNAP25—bipolar disorder	0.000123	0.000169	CbGpPWpGaD
Afatinib—ERBB4—Disease—INS—bipolar disorder	0.000122	0.000167	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—NRG1—bipolar disorder	0.000121	0.000166	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—DRD4—bipolar disorder	0.000121	0.000166	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—TSHB—bipolar disorder	0.00012	0.000165	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—TPH2—bipolar disorder	0.00012	0.000165	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CACNB2—bipolar disorder	0.00012	0.000165	CbGpPWpGaD
Afatinib—ABL1—Immune System—S100B—bipolar disorder	0.00012	0.000165	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—NRG1—bipolar disorder	0.000119	0.000164	CbGpPWpGaD
Afatinib—LCK—Immune System—HLA-E—bipolar disorder	0.000118	0.000163	CbGpPWpGaD
Afatinib—EGFR—Disease—GSK3A—bipolar disorder	0.000118	0.000163	CbGpPWpGaD
Afatinib—LCK—Disease—SNAP25—bipolar disorder	0.000118	0.000163	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—DPYD—bipolar disorder	0.000118	0.000162	CbGpPWpGaD
Afatinib—EGFR—Immune System—ADCY2—bipolar disorder	0.000117	0.000162	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TRPC3—bipolar disorder	0.000115	0.000159	CbGpPWpGaD
Afatinib—LCK—Disease—GSK3A—bipolar disorder	0.000114	0.000157	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—ADCY2—bipolar disorder	0.000114	0.000156	CbGpPWpGaD
Afatinib—LCK—Immune System—ADCY2—bipolar disorder	0.000113	0.000156	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TCF7L2—bipolar disorder	0.000113	0.000156	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—NDUFV2—bipolar disorder	0.000113	0.000155	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—GSK3B—bipolar disorder	0.000113	0.000155	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—DRD2—bipolar disorder	0.000112	0.000155	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TRPC3—bipolar disorder	0.000111	0.000153	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—ADM—bipolar disorder	0.00011	0.000152	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CACNA1C—bipolar disorder	0.00011	0.000151	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—AKR1C4—bipolar disorder	0.000109	0.00015	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HTR2A—bipolar disorder	0.000109	0.00015	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—GSK3B—bipolar disorder	0.000108	0.000149	CbGpPWpGaD
Afatinib—EGFR—Disease—ADCY2—bipolar disorder	0.000108	0.000149	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—GSK3B—bipolar disorder	0.000108	0.000149	CbGpPWpGaD
Afatinib—EGFR—Disease—TCF7L2—bipolar disorder	0.000108	0.000149	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TSHB—bipolar disorder	0.000107	0.000148	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PDE4B—bipolar disorder	0.000107	0.000148	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TACR1—bipolar disorder	0.000107	0.000148	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HTR2A—bipolar disorder	0.000107	0.000148	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PIK3C2A—bipolar disorder	0.000107	0.000147	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—ADM—bipolar disorder	0.000106	0.000146	CbGpPWpGaD
Afatinib—ABL1—Immune System—NRG1—bipolar disorder	0.000106	0.000145	CbGpPWpGaD
Afatinib—LCK—Disease—ADCY2—bipolar disorder	0.000105	0.000144	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—GSK3B—bipolar disorder	0.000104	0.000143	CbGpPWpGaD
Afatinib—LCK—Disease—TCF7L2—bipolar disorder	0.000104	0.000143	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PDE4B—bipolar disorder	0.000103	0.000142	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TSHB—bipolar disorder	0.000103	0.000142	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TACR1—bipolar disorder	0.000103	0.000142	CbGpPWpGaD
Afatinib—EGFR—Immune System—S100B—bipolar disorder	0.000102	0.000141	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NTRK1—bipolar disorder	0.000102	0.00014	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IL1B—bipolar disorder	9.98e-05	0.000137	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—S100B—bipolar disorder	9.89e-05	0.000136	CbGpPWpGaD
Afatinib—LCK—Immune System—S100B—bipolar disorder	9.86e-05	0.000136	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	9.86e-05	0.000136	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IL1B—bipolar disorder	9.83e-05	0.000135	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—NR1D1—bipolar disorder	9.82e-05	0.000135	CbGpPWpGaD
Afatinib—IRAK1—Immune System—GSK3B—bipolar disorder	9.81e-05	0.000135	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	9.79e-05	0.000135	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—SNAP25—bipolar disorder	9.58e-05	0.000132	CbGpPWpGaD
Afatinib—BLK—Immune System—IL1B—bipolar disorder	9.46e-05	0.00013	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—NCAN—bipolar disorder	9.39e-05	0.000129	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—SLC5A3—bipolar disorder	9.2e-05	0.000127	CbGpPWpGaD
Afatinib—EGFR—Immune System—NRG1—bipolar disorder	9.03e-05	0.000124	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HTR2A—bipolar disorder	8.91e-05	0.000123	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR1A—bipolar disorder	8.89e-05	0.000122	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—GSK3B—bipolar disorder	8.77e-05	0.000121	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TAC1—bipolar disorder	8.75e-05	0.00012	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NRG1—bipolar disorder	8.73e-05	0.00012	CbGpPWpGaD
Afatinib—LCK—Immune System—NRG1—bipolar disorder	8.7e-05	0.00012	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—POMC—bipolar disorder	8.7e-05	0.00012	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—INS—bipolar disorder	8.65e-05	0.000119	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—GSK3B—bipolar disorder	8.64e-05	0.000119	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—DRD1—bipolar disorder	8.58e-05	0.000118	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR2C—bipolar disorder	8.58e-05	0.000118	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—POMC—bipolar disorder	8.57e-05	0.000118	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR1A—bipolar disorder	8.56e-05	0.000118	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—INS—bipolar disorder	8.52e-05	0.000117	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ADCY2—bipolar disorder	8.48e-05	0.000117	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TAC1—bipolar disorder	8.43e-05	0.000116	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NTRK2—bipolar disorder	8.35e-05	0.000115	CbGpPWpGaD
Afatinib—EGFR—Disease—NRG1—bipolar disorder	8.34e-05	0.000115	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—DRD3—bipolar disorder	8.31e-05	0.000114	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—GSK3A—bipolar disorder	8.28e-05	0.000114	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—DRD1—bipolar disorder	8.27e-05	0.000114	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR2C—bipolar disorder	8.27e-05	0.000114	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—DRD4—bipolar disorder	8.07e-05	0.000111	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NTRK2—bipolar disorder	8.05e-05	0.000111	CbGpPWpGaD
Afatinib—LCK—Disease—NRG1—bipolar disorder	8.04e-05	0.000111	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—DRD3—bipolar disorder	8.01e-05	0.00011	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—GSK3A—bipolar disorder	7.98e-05	0.00011	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HTR2A—bipolar disorder	7.87e-05	0.000108	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—DRD4—bipolar disorder	7.78e-05	0.000107	CbGpPWpGaD
Afatinib—ABL1—Immune System—GSK3B—bipolar disorder	7.67e-05	0.000106	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—ADCY2—bipolar disorder	7.6e-05	0.000105	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TCF7L2—bipolar disorder	7.57e-05	0.000104	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—DRD2—bipolar disorder	7.52e-05	0.000103	CbGpPWpGaD
Afatinib—EGFR—Disease—MTHFR—bipolar disorder	7.51e-05	0.000103	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—ADCY2—bipolar disorder	7.32e-05	0.000101	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TCF7L2—bipolar disorder	7.29e-05	0.0001	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—COMT—bipolar disorder	7.26e-05	0.0001	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—DRD2—bipolar disorder	7.24e-05	9.97e-05	CbGpPWpGaD
Afatinib—LCK—Disease—MTHFR—bipolar disorder	7.24e-05	9.96e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL1B—bipolar disorder	7.22e-05	9.93e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—MAOA—bipolar disorder	7.21e-05	9.93e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—POMC—bipolar disorder	7.12e-05	9.8e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NTRK1—bipolar disorder	6.81e-05	9.37e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CLOCK—bipolar disorder	6.65e-05	9.15e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—S100B—bipolar disorder	6.62e-05	9.11e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NTRK1—bipolar disorder	6.56e-05	9.03e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—GSK3B—bipolar disorder	6.56e-05	9.02e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—TSHB—bipolar disorder	6.48e-05	8.92e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—TPH2—bipolar disorder	6.48e-05	8.92e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CACNB2—bipolar disorder	6.48e-05	8.92e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—S100B—bipolar disorder	6.38e-05	8.78e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—DPYD—bipolar disorder	6.38e-05	8.78e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—GSK3B—bipolar disorder	6.34e-05	8.73e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—GSK3B—bipolar disorder	6.32e-05	8.7e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—POMC—bipolar disorder	6.29e-05	8.66e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—INS—bipolar disorder	6.25e-05	8.61e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—GSK3B—bipolar disorder	6.05e-05	8.33e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—INS—bipolar disorder	5.97e-05	8.22e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CACNA1C—bipolar disorder	5.93e-05	8.16e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—MTHFR—bipolar disorder	5.87e-05	8.08e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NRG1—bipolar disorder	5.84e-05	8.04e-05	CbGpPWpGaD
Afatinib—LCK—Disease—GSK3B—bipolar disorder	5.83e-05	8.03e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PIK3C2A—bipolar disorder	5.78e-05	7.95e-05	CbGpPWpGaD
Afatinib—LCK—Disease—INS—bipolar disorder	5.75e-05	7.92e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL1B—bipolar disorder	5.65e-05	7.77e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NRG1—bipolar disorder	5.63e-05	7.75e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR2A—bipolar disorder	5.27e-05	7.25e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—SNAP25—bipolar disorder	5.18e-05	7.13e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR2A—bipolar disorder	5.07e-05	6.98e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL1B—bipolar disorder	4.83e-05	6.64e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—POMC—bipolar disorder	4.69e-05	6.46e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—INS—bipolar disorder	4.67e-05	6.43e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL1B—bipolar disorder	4.65e-05	6.4e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ADCY2—bipolar disorder	4.59e-05	6.31e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—GSK3B—bipolar disorder	4.24e-05	5.83e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—POMC—bipolar disorder	4.2e-05	5.79e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—INS—bipolar disorder	4.18e-05	5.76e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—GSK3B—bipolar disorder	4.09e-05	5.62e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—POMC—bipolar disorder	4.05e-05	5.58e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—INS—bipolar disorder	4.03e-05	5.55e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—COMT—bipolar disorder	3.93e-05	5.4e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—MAOA—bipolar disorder	3.9e-05	5.37e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—MTHFR—bipolar disorder	3.17e-05	4.37e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—POMC—bipolar disorder	2.54e-05	3.49e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—INS—bipolar disorder	2.52e-05	3.47e-05	CbGpPWpGaD
